Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery
Recruiting
Phase 3
Interventional Study
Delirium
Surgery-Complications
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 60 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 46 (estimated)
- Sponsor
- Washington University School of Medicine · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The investigation will establish biological plausibility and infrastructure required for a multisite clinical trial evaluating the re-purposing of fluvoxamine to mitigate postoperative delirium risk in geriatric patients undergoing non-cardiac non-intracranial surgery.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* English-speaking
* elective non-cardiac or non-intracranial surgery requiring at least a 2-day hospital length of stay
Exclusion Criteria:
* Received investigational drug within the last 7 weeks
* lack of capacity to provide informed consent
* prior known intolerance or alle…
Contacts